AMCHI GENDYNAMY SCIENCE CORP Financial Statements (2025 and earlier)
Company Profile
| Business Address |
650 TAMARACK BREA, CA 92821 |
| State of Incorp. | |
| Fiscal Year End | December 31 |
| Industry (SIC) | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) (USD)
| 6/30/2016 MRQ | 12/31/2015 | |||
|---|---|---|---|---|
| ASSETS | ||||
| Current Assets | ||||
| Cash, cash equivalents, and short-term investments | 59,837 | |||
| Cash and cash equivalents | 59,837 | |||
| Prepaid expense | 7,400 | |||
| Total current assets: | 67,237 | |||
| Noncurrent Assets | ||||
| Intangible assets, net (including goodwill) | 10,400 | |||
| Intangible assets, net (excluding goodwill) | 10,400 | |||
| Total noncurrent assets: | 10,400 | |||
| TOTAL ASSETS: | 77,637 | |||
| LIABILITIES AND EQUITY | ||||
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 15,000 | |||
| Accounts payable | 15,000 | |||
| Debt | 60,445 | |||
| Due to related parties | 102,172 | |||
| Total current liabilities: | 177,617 | |||
| Noncurrent Liabilities | ||||
| Total liabilities: | 177,617 | |||
| Equity | ||||
| Equity, attributable to parent, including: | (99,980) | |||
| Common stock | 2,050 | |||
| Additional paid in capital | 1,751 | |||
| Accumulated deficit | (101,731) | |||
| Other undisclosed equity, attributable to parent | (2,050) | |||
| Total equity: | (99,980) | |||
| TOTAL LIABILITIES AND EQUITY: | 77,637 | |||
Income Statement (P&L) (USD)
| 6/30/2016 TTM | 12/31/2015 | ||
|---|---|---|---|
| Operating expenses | (101,024) | ||
| Operating loss: | (101,024) | ||
| Loss from continuing operations: | (101,024) | ||
| Loss before gain (loss) on sale of properties: | (101,024) | ||
| Net loss available to common stockholders, diluted: | (101,024) | ||
Comprehensive Income (USD)
| 6/30/2016 TTM | 12/31/2015 | ||
|---|---|---|---|
| Net loss: | (101,024) | ||
| Comprehensive loss, net of tax, attributable to parent: | (101,024) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.